What is the best way to increase serum albumin in a dialysis patient with hypoalbuminemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increasing Serum Albumin in Dialysis Patients

The best approach to increase serum albumin in dialysis patients is to ensure adequate protein intake (1.2-1.3 g/kg/day for peritoneal dialysis, 1.2 g/kg/day for hemodialysis), maintain adequate dialysis clearance, prevent and treat catabolic illness, and address specific nutritional barriers—not albumin infusion, which is not recommended for dialysis patients. 1, 2

Primary Treatment Strategy

The foundation of managing hypoalbuminemia in dialysis patients involves three core interventions that should be implemented simultaneously:

1. Optimize Nutritional Intake

  • Target protein intake of 1.2-1.3 g/kg body weight/day for peritoneal dialysis patients due to significant protein losses in dialysate 1
  • Target protein intake of 1.2 g/kg/day for hemodialysis patients 1
  • Ensure adequate caloric intake of 35 kcal/kg/day for patients under 60 years, or 30-35 kcal/kg/day for those 60 years and older 1
  • Aim for normalized protein nitrogen appearance (nPNA) ≥0.9 g/kg/day, which indicates adequate protein intake in the absence of significant comorbidity 1
  • Monitor nutritional status frequently with a renal dietitian to ensure dietary goals are being met 1

2. Ensure Adequate Dialysis Clearance

  • Maintain Kt/Vurea at or above recommended targets (typically Kt/Vurea of 2.0 for peritoneal dialysis) 1
  • Monitor serum albumin at least every 4 months, with more frequent monitoring during acute illness or when albumin is declining 1, 2
  • Evaluate dialysis prescription if albumin is declining despite adequate nutrition, as inadequate clearance may suppress appetite and protein intake 1

3. Prevent and Treat Catabolic Illness

  • Identify and treat underlying inflammation, as inflammatory cytokines directly suppress hepatic albumin synthesis even with adequate protein intake 2, 3
  • Measure C-reactive protein or other inflammatory markers to distinguish inflammation-driven hypoalbuminemia from pure malnutrition 2, 3
  • Treat infections, peritonitis, and other acute illnesses promptly as these drive catabolism 1

Addressing Specific Barriers to Albumin Improvement

A targeted intervention addressing patient-specific nutritional barriers has been shown to increase albumin levels by 0.21 g/dL over 12 months compared to usual care 4. Key barriers to address include:

  • Poor nutritional knowledge: Provide education on high-protein foods and dietary requirements 4
  • Poor appetite: Consider prokinetic agents if delayed gastric emptying is present, as this can increase albumin from 3.1 to 3.5 g/dL over 6 months 5
  • Help needed with shopping or cooking: Arrange social services or meal delivery 4
  • Difficulty swallowing: Refer to speech therapy and modify food textures 4
  • Gastrointestinal symptoms: Evaluate for gastroparesis, constipation, or other GI issues 4, 5
  • Metabolic acidosis: Correct with bicarbonate supplementation 1, 4

Dialyzer Membrane Considerations

For hemodialysis patients using bioincompatible membranes (such as cuprammonium), switching to biocompatible membranes (such as polysulfone) can increase serum albumin levels from 3.22 to 3.35 g/dL 6. However, avoid protein-leaking or medium cut-off membranes that increase albumin losses into dialysate, as approximately 60% of HD patients already have albumin <4.0 g/dL 7.

What NOT to Do

Albumin infusion is explicitly not recommended for dialysis patients for prevention or treatment of intradialytic hypotension or to increase serum albumin levels 2. The evidence shows:

  • Increasing dialysis dose (Kt/Vurea) increases protein intake but does not consistently increase serum albumin 1
  • There are no convincing data that increasing small-molecule clearance improves nutritional status or serum albumin 1
  • Albumin infusion is expensive ($130/25g) and carries risks including fluid overload, hypotension, and anaphylaxis 2

Target Goals and Monitoring

  • Target serum albumin ≥4.0 g/dL (using bromcresol green method) as the highest albumin level possible should be the goal 1, 2
  • A stable or rising albumin value is desirable, as each 0.1 g/dL decrease is associated with 6% increased death risk and 5% increased hospitalization days 1, 3
  • Monitor in context of overall clinical status including comorbid diseases, peritoneal transport type, delivered dialysis dose, and inflammation markers 1

Common Pitfalls to Avoid

  • Assuming hypoalbuminemia is solely due to malnutrition when inflammation may be the primary driver—always measure inflammatory markers 2, 3
  • Failing to recognize that albumin synthesis is suppressed by catabolic illness even with adequate protein intake 2, 3
  • Not addressing fluid overload, as hemodilution from excess fluid decreases serum albumin concentration 3
  • Overlooking gastroparesis, particularly in diabetic patients, which can prevent adequate nutrient absorption despite adequate intake 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Hypoalbuminemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Etiologies of Hypoalbuminemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006

Research

Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Research

Effect of biocompatibility of hemodialysis membranes on serum albumin levels.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis.

International journal of nephrology and renovascular disease, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.